Discover our collection of materials about the M²OLIE research campus. Explore the milestones and achievements we’ve documented since 2013 and see how they continue to shape our journey.
This film was produced on the occasion of the mid-term of the second funding phase (2019-2024). Since 2013, the Mannheim Research Campus M²OLIE has been working successfully on the vision of transforming the widespread disease of cancer into a chronic disease with currently 28 partners from science and industry. The innovative strength of M²OLIE is decisively shaped by the long-term orientation of the projects under one roof and the interdisciplinary cooperation at eye level.
Produktion: AV Medien
The treatment pathway as a one-stop shop for the benefit of the patient: The M²OLIE short film explains the vision of the Mannheim Molecular Intervention Environment from the patient’s perspective and shows how this vision is being realized step by step on the Research Campus by means of integrative solutions. This film vividly presents the innovative closed-loop process through which both the diagnosis and treatment of cancer patients with optometastases are improved and individualized using effective automation techniques.
The film shows how M²OLIE partners are revolutionizing cancer treatment with AI, robotics, and digital processes. The goal is to develop faster, more precise, and minimally invasive therapy for patients with metastases – developed in interdisciplinary collaboration between research, medicine, and industry. Porsche Consulting contributes its digital expertise – from agile process models to the strategic positioning of M²OLIE.
Follow us on:
The following brochures offer deeper insights into our research focus areas while also giving you a vivid impression of the people, ideas, and innovations that define M²OLIE.
Since 2013, the M²OLIE Research Campus has been working to establish an innovative and patient-friendly care pathway for cancer patients with oligometastases. The anniversary publication offers insights into key milestones, research achievements, and the vision of the “Intervention Room of the Future.” Discover ten years of cutting-edge research, strong partnerships, and the next steps toward the M²OLIE Closed-Loop Process.
Since 2013, the M²OLIE Research Campus has been working together with partners from science and industry towards the vision of transforming cancer from a life-threatening to a chronic disease. The brochure “M²OLIE Highlights” provides a concise overview of the key milestones achieved halfway through the second funding phase (2019–2024), supported by the German Federal Ministry of Education and Research (BMBF). The focus lies on technological and organizational innovations along the M²OLIE Closed-Loop Process – from diagnosis to therapy. More than 40 developed products and applications, the initiation of first clinical studies, and the establishment of the “Intervention Room of the Future” highlight the success of the interdisciplinary collaboration firmly rooted in Mannheim.
The M²OLIE information flyer presents the key focus areas of the three projects of the Research Campus in its second funding phase. At the center is the innovative Closed-Loop Process, designed to provide patients with oligometastases faster, more precise, and more individualized treatment.
The first funding phase of M²OLIE (2013–2018) marked the starting point of a long-term research initiative designed to span up to 15 years. At Mannheim University Medical Center, a multidisciplinary center was established to develop innovative methods, technologies, and infrastructures aimed at reshaping diagnostics and therapy for cancer patients with oligometastases within a one-stop-shop model. Central to this vision are highly individualized and (partially) automated treatment processes, with the goal of significantly extending survival and transforming cancer into a chronic disease. The brochure illustrates how, during the first funding phase, three flagship projects and complementary cross-sectional projects laid the foundation for the visionary Closed-Loop Process.
